| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.3 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.04 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.09 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |